Mark G. Currie, Chief Scientific Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 150,000 shares at $8.53 ($1.3M) on 2016-02-24, disclosed to the SEC on 2016-02-26.
Seasonal sale ($1.3M) by Chief Scientific Officer — this insider has traded IRWD in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| CYCN | SELL | 2020-12-30 | $121K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |